HIF-2α prolongs EGFR activity by inhibiting endocytosis and subsequent lysosomal degradation in VHL-deficient 786-O ccRCC cell lines (Zhou and Yang, 2011). Here, EPAS1 is linked to nonpapillary renal cell carcinoma.